Lp-PLA2-IN-12 manufacturers
- Lp-PLA2-IN-12
-
-
2026-04-20
- CAS:2637485-14-2
- Purity:
- Supply Ability: 10g
|
| | Lp-PLA2-IN-12 Basic information |
| | Lp-PLA2-IN-12 Chemical Properties |
| | Lp-PLA2-IN-12 Usage And Synthesis |
| Uses | Lp-PLA2-IN-12 (compound 19) is an Lp-PLA2 inhibitor. Lp-PLA2-IN-12 can be used for the study of neurodegenerative related diseases such as Alzheimer's disease (AD), glaucoma, age-related macular degeneration (AMD), or cardiovascular disease including atherosclerosis[1]. | | References | [1] Xiao Qiong, et al. Tetracyclic pyrimidinone compounds, preparation method, composition and application thereof. Patent, CN112574221A. |
| | Lp-PLA2-IN-12 Preparation Products And Raw materials |
|
|
Tag:Lp-PLA2-IN-12(2637485-14-2)
Related Product Information
|
|
Lp-PLA2 -IN-1
1H,6H-Pyrrolo[1',2':3,4]imidazo[1,2-c]pyrimidin-1-one, 3-[[3,5-difluoro-4-[[2-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]methoxy]-7,8,8a,9-tetrahydro-, (8aS)-
1620578-11-1
1H,6H-Pyrrolo[1',2':3,4]imidazo[1,2-c]pyrimidin-1-one, 3-[[3,5-difluoro-4-[[2-(trifluoromethyl)-4-pyridinyl]oxy]phenyl]methoxy]-7,8,8a,9-tetrahydro-, (8aR)-
9H-6,8a-Ethano-1H,6H-pyrrolo[1',2':3,4]imidazo[1,2-c]pyrimidin-1-one, 3-[[4-[3-chloro-4-(trifluoromethoxy)phenoxy]-3,5-difluorophenyl]methoxy]-7,8-dihydro-
Lp-PLA2-IN-12
|